National Norms for Hospital Frailty Risk Score Among Hospitalized Adults in the USA
Christine Loyd, Taylor Miller, Shrest Nath, Yue Zhang, Richard E. Kennedy

TL;DR
This study establishes national norms for a hospital frailty risk score in the USA, showing how frailty risk varies with age, sex, and race.
Contribution
The study provides the first national normative values for the Hospital Frailty Risk Score (HFRS) stratified by age, sex, and race.
Findings
Frailty risk increases significantly with age across all sexes and races.
Black and Asian/Pacific Islander inpatients aged 90+ show the highest frailty risk.
National HFRS norms can serve as a reference for clinical and research comparisons.
Abstract
Frailty among inpatients increases risk for hospital-associated disability and death. Yet, frailty is not regularly screened in acute care due to the lack of standardized methods, the complexity of frailty, and time and energy required of hospital personnel. Thus, screening with routinely collected data provides an opportunity to assess frailty across inpatient populations. To calculate normative values for Hospital Frailty Risk Score (HFRS) among adult inpatients in the USA based on age, sex, and race. A retrospective cross-sectional analysis of the 2018 National Inpatient Sample (NIS) database. US adult inpatients aged 18y + with a focus on patients aged at least 45. Hospital Frailty Risk Score (HFRS) is a validated measure that uses ICD-10 codes to calculate frailty risk among hospitalized patients. Mean HFRS significantly increased with increasing age across sex and race (p <…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFrailty in Older Adults · Nutrition and Health in Aging · Health Systems, Economic Evaluations, Quality of Life
INTRODUCTION
Frailty is a state of cumulative decline in physiologic reserve capacity that results in diminished ability to restore homeostasis following a stressor event.^1,2^ Abundant evidence supports that being frail increases risk for a variety of negative health outcomes for patients,^3–8^ and predicts adverse outcomes among hospitalized and postoperative patients.^9,10^ The prevalence of frailty increases with age and is most commonly observed among older adults (65y +).^11^ However, evidence also supports that younger adults with multimorbidity (having at least two chronic health conditions) are at risk for frailty.^12^ Other risk factors for frailty include female sex, socioeconomic status, and number of health issues.^13,14^
Assessment of frailty in the acute care setting is of particular concern because many hospitalized patients are older and have multimorbidity.^15^ Furthermore, frailty increases risk for longer hospitalizations, development of hospital-associated disability, and death while in the hospital or after discharge.^10,16^ Identifying frailty among hospitalized patients can assist in targeting therapeutic resources to patients that would benefit most, which has the potential to benefit both the patient and the healthcare system. Despite this, frailty is not routinely screened when patients are hospitalized in acute care.^17^ Key barriers to frailty screening are lack of a gold standard assessment,^18^ the complex nature of frailty which includes psychosocial and physical components,^19^ and the fact that time and energy among hospital personnel are limited in the acute care setting so that screening for frailty might not be prioritized.^20^
Most frailty assessment methods are complicated and time-intensive, and require training of hospital personnel to ensure interrater reliability.^21–23^ Use of hospital administrative data is a potential method to circumvent these issues. The Hospital Frailty Risk Score (HFRS) was recently developed and validated to identify patients with frailty using diagnostic (ICD-10) codes, a universal coding system for medical conditions.^24^ ICD codes are routine data collected when patients are hospitalized, which allows frailty assessment without additional data collection and allows frailty analysis on a large scale. The objective of this investigation was to calculate the national norms for HFRS among adult inpatients using a US national sample stratified by age, sex and race to promote more widespread use of this instrument.
METHODS
Data Source
The Healthcare Cost and Utilization Project (HCUP) by the Agency of Healthcare Research and Quality (AHRQ) has resulted in development of the Nationwide Inpatient Sample (NIS) databases. The NIS is the largest publicly available all-payer inpatient dataset containing data from hospitals across the USA on more than 7 million hospitalizations each year.^25^ When weighted to the US population, the NIS dataset is representative of 97% of hospital discharges in the USA annually. The NIS includes data on inpatients admitted to acute care excluding observation stays. Admitted patients come from the community, from long-term and subacute care, and from rehabilitation facilities and reports on demographics, healthcare utilization, and diagnoses and procedures. Primary and secondary diagnoses are provided using International Classification of Diseases–10th Revision (ICD10) codes.^26^ The NIS database does not track readmissions of individual patients, so that each hospitalization is documented as being unique. The NIS dataset is provided in aggregate across hospitals and hospital admissions so this is not considered human subjects research by the UAB Institutional Review Board and thus not requiring protocol approval. Human ethics and consent to participate declarations: not applicable.
Study Population
The study population were US adult patients hospitalized in 2018 at a hospital participating in providing data to the NIS. Demographic information (age, race, sex) and primary and secondary diagnoses via ICD-10 codes were extracted from the 2018 database and used in analysis. Since frailty is most common in older inpatients,^15^ this analysis focused on patients 45y and older by stratifying these patients into groups using 5-year intervals (45–49 years to 85–89 years). Patients aged 90y + were grouped into a single group as were patients aged 18–44 years. Patients were also grouped by sex (male, female) and race (White, Black, Hispanic, Asian or Pacific Islander, or Native American). The social construct of race was included in our analysis in light of evidence supporting that racial minority groups are at increased risk for poorer health outcomes.^27,28^
Frailty Assessment
The Hospital Frailty Risk Score (HFRS) is a validated assessment for screening for frailty and calculating frailty risk among hospitalized patients.^24^ The HFRS is calculated using ICD-10 codes for 109 diagnoses and factors influencing health status (Z codes) identified as being associated with frailty risk and each ICD-10 code was assigned a value ranging from 0.1 to 7.1 relative to its relationship to frailty severity. The sum of the values for each diagnosis yield the HFRS, with higher summary scores corresponding to higher risk for frailty.^24^ The initial validation of the HFRS categorized scores into frailty risk groupings—low risk (< 5), intermediate risk (5–15), and high risk (˃15),^24^ however for this study, we have provided HFRS as a continuous variable to provide normative values. Previous validation studies have demonstrated higher scores on the HFRS are associated with longer hospital stays and greater 30-day readmissions and mortality.^24^
Statistical Analysis
Characteristics of the study population were described using means and standard deviations (SD) for age as a continuous variable and frequencies (percentages) for categorical variables (age group, sex group, and race group). Differences between groups were analyzed using independent samples t tests for continuous variables and Pearson’s chi-square tests for categorical variables. Norms for HFRS were calculated as weighted means, SDs, and percentile points using the survey package version 4.2.0 in the R programming environment (R Core Development Team, Vienna, Austria).^29^ Weighting was performed using values supplied in the NIS dataset to provide norms for the US national inpatient population.^30^ Norms were stratified by 5-year age intervals to compare frailty across age groups, as well as sex and race.
RESULTS
The characteristics of the study population (N = 6,051,974) are presented in Table 1. The mean age of the population was 58.2 years (SD = 27.3), and most inpatients were 45 years and older (72.1%) with the largest age groups being between age 55 and 79 years. The majority of inpatients were female (57.4%) and White (69%). The mean Hospital Frailty Risk Score (HFRS) for all inpatients was 6.55 (SD = 5.34). Table 1. Study Population Characteristics Are Presented Including Mean Age (SD), Number of Hospitalizations (%) Based on Age Group, Race Group, and Sex Group, and Mean HFRS (SD). HFRS Hospital Frailty Risk ScoreAllN**N = 6,051,974Age (years), mean (SD)58.2 (20.2)6,051,974Age group, no. (%)6,051,974 18–441,687,772 (27.9%) 45–49293,937 (4.86%) 50–54378,534 (6.25%) 55–59492,857 (8.14%) 60–64551,201 (9.11%) 65–69578,068 (9.55%) 70–74568,088 (9.39%) 75–79505,829 (8.36%) 80–84420,564 (6.95%) 85–89326,616 (5.40%) 90 and above248,508 (4.11%)Sex, no. (%)6,051,456 Male2,580,153 (42.6%) Female3,471,303 (57.4%)Race, no. (%)5,721,912 White3,949,442 (69.0%) Black890,717 (15.6%) Hispanic678,971 (11.9%) Asian or Pacific Islander164,466 (2.87%) Native American38,316 (0.67%)HFRS, mean (SD)6.55 (5.34)4,928,029
Tables 2, 3, and 4 illustrate mean HFRS across the study sample based on age, sex, and race. Table 2 shows that mean HFRS increased incrementally with increasing age (p < 0.001). The lowest mean score was among inpatients 18–44 years (4.03, SD = 4.07) and those 45–49 years age group (5.35, SD = 4.59) while the highest mean scores were among oldest inpatients 90y + (9.62, SD = 5.76). Table 3 shows that mean HFRS were higher among the male inpatients (6.69, SD = 5.33) compared to female (6.43, SD = 5.36; p < 0.001), and Table 4 demonstrates that the mean HFRS differed based on race and was lowest among Hispanic inpatients (6.10, SD = 5.22) and highest among Asian/Pacific Islander (6.74, SD = 5.75) and White inpatients (6.64, SD = 5.31; p < 0.001). Table 2. Hospital Frailty Risk Score Based on Age Group. Characteristics of Age Groups Are Presented Including Mean Age (SD), Number of hospitalizations (%) based on sex and race group, and mean HFRS (SD). HFRS Hospital Frailty Risk Score18–4445–4950–5455–5960–6465–6970–7475–7980–8485–8990 + *NN***** = 2,741,296N** = 293,937N** = 378,534N** = 492,857N** = 551,201N** = 578,068N** = 568,088N** = 505,829N** = 420,564N** = 326,616N** = 248,508Age (years), mean (SD)31.1 (6.98)47.1 (1.34)52.1 (1.35)57.1 (1.35)62.0 (1.35)67.0 (1.36)71.9 (1.37)76.9 (1.37)81.9 (1.36)86.9 (1.35)90.0 (0.00)6,051,974Sex, no. (%):6,051,456 Male457,076 (27.1%)146,691 (49.9%)198,488 (52.4%)264,458 (53.7%)292,014 (53.0%)295,731 (51.2%)278,956 (49.1%)240,169 (47.5%)188,295 (44.8%)133,848 (41.0%)84,427 (34.0%) Female1,230,406 (72.9%)147,214 (50.1%)180,009 (47.6%)228,355 (46.3%)259,153 (47.0%)282,312 (48.8%)289,112 (50.9%)265,649 (52.5%)232,259 (55.2%)192,762 (59.0%)164,072 (66.0%)Race, no. (%):5,721,912 White878,963 (56.0%)169,865 (61.2%)230,212 (64.2%)316,824 (67.7%)368,838 (70.4%)407,235 (74.1%)421,974 (77.9%)382,573 (79.2%)320,209 (79.7%)255,149 (81.7%)197,600 (83.1%) Black310,757 (19.8%)58,146 (20.9%)73,080 (20.4%)88,393 (18.9%)90,586 (17.3%)79,200 (14.4%)61,718 (11.4%)49,110 (10.2%)37,585 (9.36%)24,581 (7.87%)17,561 (7.38%) Hispanic297,819 (19.0%)40,255 (14.5%)44,720 (12.5%)49,777 (10.6%)49,624 (9.48%)47,061 (8.56%)42,769 (7.90%)37,092 (7.68%)31,335 (7.80%)22,993 (7.36%)15,526 (6.53%) Asian or Pacific Islander66,449 (4.24%)6867 (2.47%)7730 (2.15%)9221 (1.97%)11,047 (2.11%)12,882 (2.34%)12,261 (2.26%)11,817 (2.45%)10,911 (2.72%)8698 (2.79%)6583 (2.77%) Native American14,317 (0.91%)2621 (0.94%)3073 (0.86%)3681 (0.79%)3517 (0.67%)3291 (0.60%)2726 (0.50%)2160 (0.45%)1512 (0.38%)888 (0.28%)530 (0.22%)HFRS, mean (SD)4.03 (4.07)5.35 (4.59)5.71 (4.79)6.06 (4.93)6.43 (5.13)6.74 (5.26)7.15 (5.37)7.73 (5.54)8.40 (5.68)9.06 (5.77)9.62 (5.76)4,928,029Table 3Hospital Frailty Risk Score Based on Sex. Characteristics of Sex Groups Are Presented Including Mean Age (SD), Number of Hospitalizations (%) Based on Sex and Race Group, and Mean HFRS (SD). HFRS Hospital Frailty Risk ScoreMaleFemale*NN* = 2,580,153**N = 3,471,303Age (years), mean (SD)61.4 (17.5)55.8 (21.7)6,051,456Race, no. (%)5,721,470 White1,736,944 (71.1%)2,212,196 (67.5%) Black368,589 (15.1%)522,053 (15.9%) Hispanic263,069 (10.8%)415,853 (12.7%) Asian or Pacific Islander58,122 (2.38%)106,329 (3.24%) Native American15,938 (0.65%)22,377 (0.68%)HFRS, mean (SD)6.69 (5.33)6.43 (5.36)4,927,688Table 4Hospital Frailty Risk Score Based on Race. Characteristics of Race Groups Are Presented Including Mean Age (SD), Number of Hospitalizations (%) Based on Sex and Race Group, and Mean HFRS (SD). HFRS Hospital Frailty Risk ScoreWhiteBlackHispanicAsian or Pacific IslanderNative AmericanN**N = 3,949,442**N = 890,717**N = 678,971**N = 164,466**N = 38,316Age (years), mean (SD)61.2 (19.6)52.9 (19.2)50.4 (20.6)54.4 (21.4)51.9 (19.0)5,721,912Sex, no. (%)5,721,470 Male1,736,944 (44.0%)368,589 (41.4%)263,069 (38.7%)58,122 (35.3%)15,938 (41.6%) Female2,212,196 (56.0%)522,053 (58.6%)415,853 (61.3%)106,329 (64.7%)22,377 (58.4%)HFRS, mean (SD)6.64 (5.31)6.54 (5.48)6.10 (5.22)6.74 (5.75)6.43 (5.03)4,677,566
Tables 5 and 6 provide the normative values (mean, SD, 5th–95th percentile) for HFRS based on age group and sex or race group. Table 5 illustrates that mean HFRS and percentile values increased with age for males and females. For male inpatients, the mean range was 4.85 (SD = 4.44) among those 18–44 years to 9.60 (SD = 5.80) among those 90y + . The median range for males was 3.50 (18–44 years) to 8.70 (90y +). For female inpatients, the mean range was 3.49 (SD = 3.71) among those 18–44 years to 9.62 (SD = 5.74) among those 90y + . The median range for females was 2.10 (18–44 years) to 8.70 (90y +). The mean HFRS and the percentile values were marginally higher among male inpatients in the younger age groups (< 70 years) compared to females. However, among inpatients 70y + , the mean HFRS and percentiles were slightly higher among females. Table 5. Normative HFRS by Sex Across Age Groups. Mean, SD, and Percentiles for Mean HFRS Are Presented. HFRS Hospital Frailty Risk ScoreAge groupsSexStatistic18–4445–4950–5455–5960–6465–6970–7475–7980–8485–8990 + MaleMean4.855.495.786.106.476.767.147.708.349.029.60SD4.444.694.834.985.185.295.375.545.675.785.805th percentile0.500.700.700.700.801.101.301.401.501.501.9025th percentile1.702.002.202.302.502.703.003.404.004.605.2050th percentile (median)3.504.104.404.705.105.405.906.507.208.008.7075th percentile6.607.608.008.509.109.4010.0010.7011.5012.3013.0095th percentile13.8014.8015.4015.9016.7017.1017.6018.5019.2020.0020.50FemaleMean3.495.205.636.016.396.717.167.758.449.099.62SD3.714.494.744.885.075.225.385.545.695.775.745th percentile0.400.500.500.600.700.901.101.401.501.501.9025th percentile1.101.902.102.302.502.703.003.504.004.705.3050th percentile (median)2.103.904.304.705.105.405.906.507.408.108.7075th percentile4.607.207.808.408.909.4010.0010.8011.7012.4013.0095th percentile11.1014.1015.1015.6016.3017.0017.6018.4019.3020.0020.40Table 6Normative HFRS by Race Across Age Groups. Mean, SD, and Percentiles for Mean HFRS Are Presented. HFRS Hospital Frailty Risk ScoreAge groupsRaceStatistic < 4545–4950–5455–5960–6465–6970–7475–7980–8485–8990 + WhiteMean4.005.235.595.936.286.556.997.588.278.959.50SD4.004.524.714.865.045.145.285.445.595.685.675th percentile0.400.500.500.700.700.901.201.401.501.501.9025th percentile1.501.902.002.302.302.602.903.303.904.605.2050th percentile (median)2.603.904.204.604.905.205.706.407.208.008.6075th percentile5.407.207.808.308.809.209.8010.6011.4012.2012.8095th percentile12.2014.3015.0015.6016.2016.7017.3018.1018.9019.7020.10BlackMean4.215.656.016.447.007.568.078.639.279.9410.47SD4.164.754.945.135.395.625.816.006.136.256.225th percentile0.400.500.700.701.001.301.401.501.501.802.2025th percentile1.502.202.302.603.003.303.704.104.605.205.8050th percentile (median)2.804.404.705.205.706.306.807.408.008.809.5075th percentile5.807.808.308.909.6010.4011.1011.8012.7013.6014.2095th percentile12.6014.9015.7016.4017.5018.5019.4020.3021.1021.9022.20HispanicMean4.005.395.756.106.496.837.277.868.469.119.66SD4.114.534.784.915.115.245.435.615.715.885.885th percentile0.400.500.500.700.800.901.201.401.501.501.9025th percentile1.302.002.202.302.602.803.103.504.004.605.2050th percentile (median)2.504.104.504.805.205.606.006.707.308.108.7075th percentile5.507.508.008.509.109.5010.1010.9011.7012.5013.1095th percentile12.3014.4015.1015.8016.4017.1017.8018.7019.6020.4020.70Asian or Pacific IslanderMean3.595.455.846.286.537.017.278.148.809.8510.48SD4.024.855.125.355.345.615.495.985.996.266.205th percentile0.400.500.500.700.801.001.201.401.401.802.2025th percentile1.001.802.102.302.402.803.003.704.205.105.8050th percentile (median)2.004.004.404.905.105.605.906.807.608.609.5075th percentile4.807.608.108.709.109.7010.1011.2012.1013.4014.1095th percentile11.9015.0015.6016.5017.0017.9018.1019.7020.3021.8022.20Native AmericanMean4.826.136.646.656.687.127.397.848.578.609.46SD4.394.624.914.764.885.295.285.285.575.345.795th percentile0.400.700.700.901.001.101.401.401.501.501.5025th percentile1.502.602.903.003.003.003.303.804.304.705.1050th percentile (median)3.405.105.605.605.606.006.306.807.307.708.3075th percentile6.908.409.309.409.509.9010.3010.8012.1011.7013.4095th percentile13.7015.0015.9015.7015.9017.3017.4017.6019.0018.8020.90
Table 6 demonstrates that mean HFRS and percentile values increase with increasing age among White, Black, Hispanic, Asian/Pacific Islander, and Native American inpatients. Mean HFRS was highest among Native American inpatients for the youngest age groups < 45 years, 45–49 years, 50–54 years, and 55–59 years ranging from 4.82 (SD = 4.39) to 6.65 (SD = 4.76). Mean scores were highest among Black inpatients for age groups 60–64 years, 65–69 years, 70–74 years, 75–79 years, 80–84 years, and 85–89 years ranging from 7.00 (SD = 5.39) to 9.94 (SD = 6.25). Alternatively, among the older age groups (65y +), White inpatients had the lowest mean HFRS compared to the minority races (with the exception of Native American inpatients in the 85–89 years and 90y + age groups). Among the oldest inpatients (90y +), the highest mean HFRS was observed among Asian/Pacific Islander (10.48, SD = 6.20) and Black inpatients (10.47, SD = 6.22). The percentile values showed a similar trend with median scores highest among younger Native American inpatients, while among the older inpatients median scores were highest among Black and Asian/Pacific Islander inpatients.
DISCUSSION
We performed a nationwide assessment of frailty risk among US adult inpatients using the Hospital Frailty Risk Score (HFRS), a valid and accurate tool for identifying frailty risk among hospitalized patients.^24^ The initial validation of HFRS provided a description of low, intermediate, and high risk for frailty based on diagnoses and provides context for risk of post-admission outcomes (30-day mortality, longer length of stay, and re-admission) based on frailty risk category.^24^ Our study builds on these findings by providing normative values for HFRS in the US population stratified by age, sex, and race, which can allow assessment of inpatients for risk of frailty and associated outcomes using these norms. To the best of our knowledge, only one other study has provided normative values for a frailty index in a population-based sample, likely due to the difficulty in administering frailty assessments to a large sample of individuals.^31^ Normative values for the HFRS, an index based on more readily available ICD-10 codes, can help promote widespread use of frailty assessment in the hospital setting and comparison among inpatient populations.
Assessing inpatients for frailty risk can be beneficial in identifying patients at risk of adverse outcomes such as hospital-associated disability, increased length of hospitalization, and death.^10,16,32^ As the older adult population grows in size, this will be particularly important because older age is associated with higher frailty risk.^33,34^ In agreement with a recent systematic review and meta-analysis showing that frailty prevalence among community-dwelling adults increased from 11% among those aged 50–59 years to 51% among those aged 90y + ,^33^ our study identified that mean HFRS among US inpatients increases incrementally with increasing age, peaking among those in the oldest age group (90y +). The increase in frailty risk with age is likely due to multiple factors including physiologic decline, psychosocial changes, and multimorbidity.^34,35^ As life expectancy improves, it is possible that the prevalence of frailty and total time spent frail will increase among older adults^36^ making it an even more significant predictor of health outcomes during hospitalization.
We also present findings herein showing that older inpatients (65y +) that are female (compared to male) and racial minority (particularly Black, Hispanic and Asian/Pacific Islander compared to White) have higher mean and median HFRS. These findings are in line with other research among community-dwelling older adults that identified higher prevalence of frailty among women and Black and Hispanic older adults.^33,34,37,38^ Despite females living longer and representing an increasing proportion of hospitalizations among older age groups in the present study (see Table 2); the biological changes that occur with menopause in conjunction with psychosocial and behavioral changes with age likely contribute to increased frailty risk among older women.^39^ Additionally, while not directly measured as part of the HFRS, greater frailty risk among racial minority older inpatients might be associated with socioeconomic disparities and barriers to accessing affordable healthcare.^40,41^ Differences in environmental factors could also play a role in this observation as well.^42^
National norms for HFRS can be useful for both healthcare professionals and researchers. Clinically, the HFRS norms provide a standardized tool for assessing frailty risk among patients hospitalized in the USA based on age, sex, and race to identify those in need of additional supportive services to mitigate negative outcomes. For example, if a 70-year-old Black male patient was admitted with a HFRS of 9.0, this score could be compared to the national norms presented herein indicating that this patient’s HFRS is higher than the typical mean score for someone of a similar age, sex, and race and between the 50th and 75th percentile. A score of 9.0 puts this patient in an intermediate risk of frailty and poor outcomes post-admission indicating this patient might benefit from additional supportive services.^24^ In research, the norms can serve as a reference tool to compare study patients to a national average for hospital frailty risk to determine representativeness of research samples to the general inpatient population. The norms can also provide a method for comparative studies assessing frailty risk across geography, hospitals or hospital systems, and patient populations.
A major strength of this study is the use a national database that provides a representative sample of adult inpatients across the USA. The sample is racially diverse and spans ages from 18 to 90y + , though it does not provide data on sex outside of male and female and does not differentiate between sex assigned at birth and gender identity. Other limitations of the NIS database include not being able to distinguish between preexisting conditions and conditions at hospital admission,^43^ missing data for demographics and other variables, and differences in diagnostic coding across hospitals. Further, due to data de-identification by the AHRQ, we cannot state that all observations were unique. It is possible that a single patient was readmitted, and each hospitalization was documented as a separate observation in the database. This generally leads to overestimation of the variability and decreased probability of statistical significance, but these effects should be minimal considering the sample size of our study. The large sample size of the NIS also means that small differences that were detected may be statistically but not clinically significant, particularly since a minimum clinically important difference (MCID) for the HFRS has not been established. Additionally, the data used in this analysis was collected prior to the COVID-19 pandemic and thus may not reflect change to inpatient demographics, health, or frailty during the pandemic. It is expected, though not proven, that these changes would become less in the post-COVID era. Additionally, the use of ICD codes for assessing frailty via the HFRS might not capture all relevant clinical details related to frailty status including those related to social determinants of health, as the HFRS incorporates Z codes for mobility and caregiver dependency but not socioeconomic and psychosocial factors. Furthermore, diagnostic codes during hospitalization may not be finalized until discharge, which might present a barrier to practical use of the HFRS during the hospitalization itself ICD-10 coded admission diagnoses may still be used for an initial estimate of frailty in such circumstances. The HFRS may also be utilized on a larger scale by hospital administrators to estimate the rates of frailty at their institutions and provide adequate level of services for their patient base, and to encourage more widespread investigations of frailty in epidemiological studies that collect EHR data but not frailty assessments.
The study presents the national normative values for HFRS among US adult inpatients using the 2018 NIS database. Mean and median scores based on age, sex, and race are provided. Ultimately, these national norms can assist in rapid assessment of frailty risk, which can affect clinical care of patients by providing an easy method to identify risk across inpatients, and research practice by providing a tool that enables comparison of frailty across inpatient populations to a national standard.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Limpawattana P, Khammak C, Manjavong M, So-Ngern A. Frailty as a predictor of hospitalization and low quality of life in geriatric patients at an internal medicine outpatient clinic: a cross-sectional study. Geriatrics (Basel). 2022;7(5). 10.3390/geriatrics 7050089.10.3390/geriatrics 7050089 PMC 949851336136798 · doi ↗ · pubmed ↗
- 2US Department of Health and Human Services. Healthcare Cost and Utilization Project. https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed 12 Aug 2024.
- 3US Department of Health and Human Services. Healthcare cost and utilization project. https://hcup-us.ahrq.gov/db/nation/nis/nisdde.jsp. Accessed 12 August 2024.
- 4US Department of Health and Human Services. Healthcare Cost and Utilization Project. https://hcup-us.ahrq.gov/db/vars/discwt/nisnote.jsp. Accessed 3 October 2024.
- 5Tazzeo C, Rizzuto D, Calderón-Larrañaga A, et al. Living longer but frailer? Temporal trends in life expectancy and frailty in older Swedish adults. J Gerontol Ser A. 2023;79(1). 10.1093/gerona/glad 212.10.1093/gerona/glad 212PMC 1073319237725986 · doi ↗ · pubmed ↗
